Detachable MOF‐Based Core/Shell Nanoreactor for Cancer Dual‐Starvation Therapy With Reversing Glucose and Glutamine Metabolisms
Small · 2023-10 · 19 (42)
DOI: 10.1002/smll.202303253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 17.06.2023. Verfasst von Huiping Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, P. …. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Research Foundation Singapore.
Abstract (Originalsprache)
Tumor‐dependent glucose and glutamine metabolisms are essential for maintaining survival, while the accordingly metabolic suppressive therapy is limited by the compensatory metabolism and inefficient delivery efficiency. Herein, a functional metal–organic framework (MOF)‐based nanosystem composed of the weakly acidic tumor microenvironment‐activated detachable shell and reactive oxygen species (ROS)‐responsive disassembled MOF nanoreactor core is designed to co‐load glycolysis and glutamine metabolism inhibitors glucose oxidase (GOD) and bis‐2‐(5‐phenylacetmido‐1,2,4‐thiadiazol‐2‐yl) ethyl sulfide (BPTES) for tumor dual‐starvation therapy. The nanosystem excitingly improves tumor penetration and cellular uptake efficiency via integrating the pH‐responsive size reduction and charge reversal and ROS‐sensitive MOF disintegration and drug release strategy. Furthermore, the degradation of MOF and cargoes release can be self‐amplified via additional self‐generation H 2 O 2 mediated by GOD. Last, the released GOD and BPTES collaboratively cut off the energy supply of tumors and induce significant mitochondrial damage and cell cycle arrest via simultaneous restriction of glycolysis and compensatory glutamine metabolism pathways, consequently realizing the remarkable triple negative breast cancer killing effect in vivo with good biosafety via the dual starvation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, P. R. China.
- School of Life Science, Northwestern Polytechnical University, Xian, 710072, China.
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore, 637371, Singapore.
ORCID-Profile: Yanli Zhao, Liangliang Dai
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- National Research Foundation Singapore
Zitieren
APA
Du, H., Meng, S., Geng, M., Zhao, P., Gong, L., Zheng, X., Li, X., Yuan, Z., Yang, H., Zhao, Y., & Dai, L. (2023). Detachable MOF‐Based Core/Shell Nanoreactor for Cancer Dual‐Starvation Therapy With Reversing Glucose and Glutamine Metabolisms. Small, 19(42). https://doi.org/10.1002/smll.202303253
Vancouver
Du H, Meng S, Geng M, Zhao P, Gong L, Zheng X, et al. Detachable MOF‐Based Core/Shell Nanoreactor for Cancer Dual‐Starvation Therapy With Reversing Glucose and Glutamine Metabolisms. Small. 2023;19(42). doi:10.1002/smll.202303253
BibTeX
@article{Du2023,
author = {Du, Huiping and Meng, Siyu and Geng, Meijuan and Zhao, Pan and Gong, Liyang and Zheng, Xinmin and Li, Xiang and Yuan, Zhang and Yang, Hui and Zhao, Yanli and Dai, Liangliang},
title = {Detachable MOF‐Based Core/Shell Nanoreactor for Cancer Dual‐Starvation Therapy With Reversing Glucose and Glutamine Metabolisms},
journal = {Small},
year = {2023},
volume = {19},
number = {42},
doi = {10.1002/smll.202303253}
}
EUVIMED